Sanaria is a biotechnology company developing vaccines protective against malaria. Sanaria’s vaccines have proven highly protective in humans. Learn more
Malaria is responsible for more childhood mortality than any other single infectious agent. Sanaria’s vaccine development efforts are focused on African children, the population most urgently in need of protection. Learn more
The I-PfSSPZ-C held its semi-annual meeting in Atlanta on November 10-11, 2016. More than 100 investigators from 35 organizations in 18 countries attended and presented the status and results of ongoing and recently completed, but unpublished, clinical trials of Sanaria® PfSPZ Vaccine, PfSPZ-CVac and PfSPZ Challenge in Tanzania, Kenya, Mali, Burkina Faso, Equatorial Guinea, Germany and multiple sites in the United States.
Professor Fred Binka Honored
Professor Fred Binka received the National Honor from the President of Ghana on
October 29, 2016. Professor Binka is a long-time Sanaria Scientific
Advisory Board member, colleague, and friend. The entire Sanaria team sends its congratulations and thanks.
FDA Fast Track Designation
Sanaria has received U.S. Food and Drug Administration (FDA) Fast Track designation for its preventative vaccine
for malaria, Sanaria® PfSPZ Vaccine. According to the FDA, 'Fast Track is a process designed to facilitate the development,
and expedite the review of drugs to treat serious conditions and fill an unmet medical
need. The purpose is to get important new drugs to the patient earlier.' Press Release
DA Visits Sanaria
In memoriam: Donald 'DA' Henderson
Sanaria joins the international public health community in remembering Donald 'DA' Henderson after his death on August 19, 2016.
Sanaria was honored to receive a visit from DA in June 2011, where after describing his relentless dedication to the eradication of Smallpox, he offered insights, advice and encouragement to Sanaria at what was a critical time in our PfSPZ Vaccine clinical development program. His tenacity and willingness to speak out when others shied away have served as an example. As a result of this visit, DA became a member of Sanaria's scientific advisory board on which he served until his death.
DA's enthusiasm to support others, particularly young scientists and budding doctors, was evident from his patience answering questions and spending time with the most junior of our interns.
Sanaria's CEO, Dr. Stephen L. Hoffman, and Exec VP of Manufacturing and Process Development, Dr. B. Kim Lee Sim, featured in an Annie Leibovitz photo shoot sponsored by the Bill and Melinda Gates Foundation, The Art of Saving a Life - Vaccine Heroes.
Sanaria Inc. September 2016 Newsletter
Sanaria's CEO, Dr. Stephen L. Hoffman, awarded the 2016 Weill Cornell Medicine Alumni Association Award of Distinction for his significant accomplishments as a physician, scientist and entrepreneur; Commencement Speech
Sanaria wins 2015 Montgomery County Bioscience Company of the Year at the 3rd Annual Montgomery County Small Business Awards; Learn More
The Government of the Republic of Equatorial Guinea announced a $48.5M support agreement with its oil sector partners, Marathon Oil, Noble Energy Inc. and AMPCO, to sponsor the clinical development of Sanaria® PfSPZ Vaccine against malaria, including a series of clinical trials from 2015 through 2018 EG Press ReleaseSanaria Press ReleaseFinancial Times Article